Showing results (201-210 of 781) with videos related to
Sort By:
Pageof 79
Cardiology in Review|October 11, 2011
Allopurinol as a cardiovascular drugAnita Kelkar, Allen Kuo, William H FrishmanCardiology in Review|August 1, 2025
The Potential of Using Glucagon-Like Peptide-1 Receptor Agonists in SepsisNoel Tomy, Benjamin Shwartzman, William H FrishmanCardiology in Review|April 26, 2024
SGLT-2 Inhibitors: Focus on DapagliflozinZoya Siddiqui, Somar Hadid, William H FrishmanCardiology in Review|August 19, 2015
Hypertension in Sub-Saharan Africa: A Contextual View of Patterns of Disease, Best Management, and Systems IssuesShanti Nulu, Wilbert S Aronow, William H FrishmanCardiology in Review|August 2, 2023
New Therapy Update Aprocitentan: An Endothelin Receptor Antagonist for the Treatment of Drug-Resistant Systemic HypertensionMichael Airo, WIlliam H Frishman, Wilbert S AronowHeart Disease (Hagerstown, Md.)|September 28, 2002
Drug therapies for mesenteric vascular diseaseHossein Tabriziani, William H Frishman, Lawrence J BrandtCardiology in Review|October 11, 2011
Subclinical hypothyroidism and cardiovascular risk: recommendations for treatmentIrene A Weiss, Noah Bloomgarden, William H FrishmanCardiology in Review|December 24, 2005
Aspirin resistance: mechanisms and clinical implicationsCostas Hanjis, William H Frishman, Robert G LernerCardiology in Review|August 19, 2008
Acute inferior wall myocardial infarction and percutaneous coronary intervention of the right coronary during active labor: a clinical report and review of the literatureBredy Pierre-Louis, Parminder Singh, William H FrishmanCardiology in Review|December 19, 2008
Fabry disease: cardiac manifestations and therapeutic optionsBredy Pierre-Louis, Anil Kumar, William H FrishmanPageof 79